Background: Obesity is strongly associated with cardiovascular diseases including systemic hypertension, coronary artery disease and heart failure. Despite several investigations the pathophysiological mechanisms involved remain unclear. We have previously shown that adipose tissue exerts a highly potent activity with an acute depressant effect on cardiomyocytes, thus suggesting direct involvement of adipose tissue in the development of heart dysfunction. Objective and Design: This study investigates the effects of adipocyte factors obtained from subcutaneous adipose tissue on the whole cardiac function by using isolated perfused rat hearts in a Langendorff mode. We recorded changes in coronary flow, developed isovolumetric left ventricular pressure, contraction rate and relaxation rate. Results: We observed a significant decrease in heart contractility parameters as well as in coronary flow within a few seconds of incubation with adipocyte factors. The cardiodepressant effects could not be blocked by the nonselective cyclooxygenase-inhibitor indomethacin. Human adipocytes release tumor necrosis factor-a, interleukin-6 (IL-6) and IL-1b into extracellular medium. These cytokines were tested for their potential effect but were, however, not responsible for the cardiodepressant effect observed. Conclusion: These data indicate that human adipocytes secrete factors with a strong acute depressant effect on cardiac force generation and coronary flow due to contraction of the coronary vessels, thus suggesting a direct role of adipose tissue in the pathogenesis of cardiac dysfunction.
Introduction
The prevalence of overweight and obesity has increased over the last decades. This has become a serious health problem, because obesity has been strongly associated with several harmful metabolic and cardiovascular disorders such as diabetes mellitus, coronary heart disease, systemic hypertension and heart failure. 1 Whether obesity mediates a risk for heart failure or coronary heart disease indirectly, 1 or even leads to cardiovascular complications directly, independent of other cardiovascular risk factors, 2 has been a topic of controversy. For instance, it has been observed that changes in the left ventricular structure and function were caused by excess of weight alone. 3 Existing data indicate that obesity is directly related to heart failure, independent of other risk factors such as systemic hypertension and diabetes mellitus; 4, 5 however, the pathophysiological mechanisms involved remain unclear. Recent studies have proposed several mechanisms explaining the pathophysiology underlying obesity-associated heart failure, including increased lipid accumulation into cardiac myocytes leading to cardiomyocyte apoptosis, 6 and hemodynamic changes inducing left ventricular remodeling and systolic dysfunction. 7 However, these mechanisms do not fully explain the development of obesity-related cardiac complications. Recent studies have also emphasized the importance of adipose tissue as a highly active endocrine organ, expressing and secreting more than 100 different bioactive substances affecting adipose metabolism itself as well as distant organs. 8, 9 The function of secretory products of human adipocytes is not completely understood; however, some of these factors may partly explain the pathogenesis of the metabolic syndrome, including type II diabetes mellitus, systemic hypertension and atherosclerosis. 10 In this context, we have recently shown that adipose tissue exerts highly potent cardiodepressant activity on isolated cardiomyocytes in vitro by attenuating intracellular Ca 2 þ levels, showing that adipose tissue and its adipokines seem to be directly involved in the pathogenesis of cardiac complications.
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In this study, we analyzed the relevance of these findings on the whole cardiac function and tested the hypothesis that adipocyte-related factors are directly involved in the pathogenesis of myocardial dysfunction by using isolated perfused hearts in a Langendorff system.
Materials and methods

Human tissues
Human white adipose tissue was obtained from healthy women (aged 21-75 years, body mass index ranging from 21.0 to 29.2 kg m
À2
, n ¼ 8) undergoing elective surgical mammary and abdominal reduction. Four patients were postmenopausal and four premenopausal. All women were otherwise free of metabolic and endocrine diseases. Informed consent was obtained from all donors before the surgical procedure. The study was approved by the ethical committee of the University of Technology, Dresden.
Isolation of human adipocytes and preparation of adipocyte-conditioned medium Adipocytes were isolated from subcutaneous human adipose tissue as previously described. 12 Briefly, after surgical removal, adipose tissue samples of 20-60 g wet weight were immediately transported to the laboratory in Dulbecco's modified Eagle's medium/Nutrient Mix F12 (Life Technologies, Karlsruhe, Germany) supplemented with 100 U ml
À1
penicillin and 100 mg ml À1 streptomycin. After removal of fibrous material and blood vessels, we digested the adipose tissue in Krebs-Ringer bicarbonate buffer containing 120 U ml À1 collagenase type IV from Clostridium histolyticum (Serva, Heidelberg, Germany). Isolated mature adipocytes were kept at 37 1C in a humidified atmosphere of 5% CO 2 , and cultured for 24 h in serum-free culture medium. Subsequently, the adipocyte-conditioned medium (AM) containing all the factors released by the adipocytes was collected and used for further experiments with isolated perfused heart preparations. Culture medium without adipocytes was incubated in the same way and used as control medium (CM).
Characterization of AM
The concentrations of leptin and the proinflammatory cytokines tumor necrosis factor-a (TNF-a), interleukin-6 (IL-6), IL-1b and IL-2 in AM and CM were determined. Leptin concentration was determined by radioimmunoassay for human leptin (Linco Research, St Charles, MO, USA). IL-6 and TNF-a concentrations were measured by chemiluminescence immunoassay for human IL-6 and TNF-a, respectively (DPC Biermann, Bad Nauheim, Germany); IL-1b and IL-2 concentrations were determined by ELISA for human IL-1b and IL-2, respectively (R&D Systems, WiesbadenNordenstadt, Germany).
Animals
Animal experiments were performed using 12-week-old wild-type WKY rats weighing between 219.0 and 320.0 g (258.9±10.1 g, mean±s.e.m., n ¼ 19). Rats were kept on a 12 h light/dark cycle with 55% humidity at an ambient temperature of 23 ± 2 1C and given food and water ad libitum.
The study was approved by the institutional animal care in Berlin, Germany.
Isolation and perfusion of adult rat hearts Hearts were isolated and perfused in the Langendorff mode as previously described. 13 In summary, hearts from anesthe- Henseleit solution was prepared at the time of the experiment and equilibrated with a mixture of 95% O 2 and 5% CO 2 yielding a pH of 7.4. The hearts were cannulated for retrograde perfusion through the aorta and connected to a perfusion apparatus from Hugo Sachs Electronic (March-Hugstetten, Germany). The corresponding software was MEM Notocord (Croissy sur Seine, France), which recorded all contractile parameters and flow data simultaneously during the measurements. Isovolumetric contractile performance was measured with an elastic latex balloon filled with a 1:1 mixture of ethanol and H 2 O and inserted through the mitral valve into the left ventricle through an incision in the left atrium. The balloon was connected to a pressure transducer (Isotec, Des Plaines, IL, USA) for continuous recording of left ventricular pressure (LVP) and heart rate. The size of the balloon was carefully matched to the ventricle size. The intraballoon pressure was individually adjusted to 14-18 mm Hg to obtain maximal contractile performance. From the recorded LVP signal, we calculated maximal rate of isovolumetric pressure increase ( þ dP/dtmax) and maximal rate of isovolumetric pressure decrease (Àdp/dtmax) as contractility parameters. Coronary flow (CF) was first adjusted at 10 ml min À1 and changes were measured with an Electromagnetic Flowmeter (Hugo Sachs Electronic, March-Hugstetten, Germany). The perfusion was carried out at 37 1C with a constant aortic pressure of 70 mm Hg.
Incubation of isolated perfused heart preparations
After a stabilization period of 10 min in which the hearts contracted with their spontaneous frequency, we fixed heart stimulation frequency at 340 beats per min and the contraction monitored until the hearts reached a steadystate contraction. Then AM or the appropriate CM was added to the perfusion solution shortly before passing the aorta in a 1:6 dilution. After incubation with AM or CM, we reperfused hearts with Krebs-Henseleit solution alone (washout) to observe reversibility of the generated effects. To determine the potential role of proinflammatory cytokines in the generated effects, we incubated hearts with a mixture of TNF-a (Sigma-Aldrich, Munich, Germany), IL-6 and IL-1b (R&D Systems Europe, Abingdon, UK) for 5 min. For each
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To investigate a possible involvement of cyclooxygenase (COX)-dependent arachidonic acid metabolites, we perfused the hearts in another set of experiments with KrebsHenseleit solution containing the nonselective COXinhibitor indomethacin in a concentration of 10 mmol l À1 (Cayman Chemicals, Ann Arbor, MI, USA). After reaching a steady-state contraction, we added AM and CM to the perfusion solution as described above.
Statistics
All values are expressed as mean ± s.e.m. We used paired Student's t-test for significance analysis. A value of Po0.05 was considered statistically significant.
Results
Effect of adipocyte factors on heart contractility After incubation with AM, we observed a significant decline in LVP from 41.5 ± 4.5 to 25.5 ± 3.7 mm Hg (38.5 ± 5.4% decrease to basal) (Figure 1 ). On the contrary, no significant changes were observed in developed LVP after incubation with CM.
Furthermore, contraction rate (CR, þ dP/dtmax) decreased from 1417.0 ± 136.1 to 863.3 ± 97.6 mm Hg s À1 (À36.8 ± 6.6%, Po0.001) and relaxation rate (RR, Àdp/dtmax) from À680.0± 200.6 to À439.6 ± 52.0 mm Hg s À1 (À44.8 ± 6.4%, Po0.001)
during incubation with AM ( Figure 2 ). Upon incubation with CM, both contraction rate and RR did not change significantly.
The cardiodepressant effect of AM occurred within a few seconds of incubation and was completely reversed after 'washout'.
Effect of adipocyte factors on CF
The incubation with AM generated a significant and reversible decline of CF simultaneous to a decrease in heart contractility parameters. CF decreased from 11.3±0.9 ml min À1 before to 7.3 ± 1.1 ml min À1 after incubation with AM (À35.5 ± 8.1%). Otherwise, no differences on CF were observed after incubation with CM ( Figure 3 ). The effect on CF was also completely reversible. 
Cardiodepressant effect is not COX dependent
Vascular endothelium releases vasocontracting and/or vasorelaxing substances. In coronary artery, endotheliumderived vasoconstrictor arachidonic acid metabolites are COX dependent.
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Proinflammatory cytokines are not responsible for the cardiodepressant effect Several cytokines including TNF-a, IL-6, IL-1b and IL-2 are believed to contribute to cardiac dysfunction during severe inflammatory process. 15 Because some of these cytokines are also released by adipocytes, we tested whether proinflammatory cytokines are responsible for the adipocyte-induced cardiodepressant effect. Concentrations of TNF-a, IL-6, IL-1b and IL-2 were measured in the AM and end concentrations in the experiment (dilution 1:6) were calculated (Table 1) . No IL-2 was detectable in AM. Incubation with TNF-a, IL-6 and IL-1b in the same concentrations as in the experiments with AM had no effect on heart contractility parameters or CF ( Figure 5 ). Leptin concentration in AM was 3.4 ng ml À1 (diluted 1:6 in experiment resulting in 0.6 ng ml
À1
). A comparison with previously published data reveals that leptin concentrations in our experiment were far below the effective threshold dose influencing heart contractility parameters. 16 
Discussion
This study reveals that mature human adipocytes from subcutaneous adipose tissue release factors that directly and acutely suppress contraction of isolated perfused hearts. Adipocyte-derived factors decrease both cardiac force generation (as observed in the suppression of LVP, CR and RR) and CF due to contraction of the coronary vessels. These cardiodepressant effects were reversible and could not be inhibited by the nonselective COX-inhibitor indomethacin.
Although a causal relationship between obesity and heart failure is largely acknowledged, 3,4 the pathophysiological mechanisms involved remain unclear. The development of heart failure in obesity has mainly been explained by altered left ventricular remodeling due to increased hemodynamic load and/or neurohormonal activation. 7 In addition, a direct causal effect of obesity on myocardium dysfunction through intramyocardial lipid accumulation has been suggested by Zhou et al. Abbreviations: AM, adipocyte-conditioned medium; IL, interleukin; ND, nondetectable; TNF-a, tumor necrosis factor-a. Mean ± s.e.m., n ¼ 6 adipocytes preparations.
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The role of adipose tissue (and its secretory products) as an active endocrine organ is gaining importance in the investigation of obesity-associated diseases. Some of these factors might be key factors involved in the onset of cardiac dysfunction in obese subjects. Leptin has been suggested to have a role in cardiovascular system physiology and pathophysiology. 17 The effect of leptin on cardiac physiology, however, is controversial. Although high doses of leptin (10-1000 nmol l
À1
) seem to directly suppress cardiac contraction in isolated cardiomyocytes, 16 physiologically relevant concentrations (25 ng ml
) abolish the negative inotropic effect of IL-1b, 18 suggesting a potential role of leptin in modulating proinflammatory effects in the heart. A cardioprotective effect of leptin was shown in recent studies with isolated perfused hearts, in which leptin (10 nmol l À1 ) caused significant reductions in infarct size after reperfusion. 19, 20 In our experiments, leptin concentrations were several orders of magnitude below the effective threshold dosages affecting heart contractility. Therefore, leptin cannot account for the cardiodepressant effect described in our system. It has recently been shown that there is an inverse relationship between adiponectin, whose synthesis is downregulated in obesity, and left atrium size being a surrogate marker of left ventricle diastolic dysfunction and heart failure, linking adiposity to heart remodeling. 21 Contrary to an antihypertrophic effect of adiponectin, 22 resistin, an adipokine implicated in type II diabetes and insulin resistance, seems to promote heart hypertrophy in rodents. 23 In humans, the pathophysiological role of resistin has been questioned. Unlike mice, resistin is almost not detectable in mature human adipocytes. 24 It is therefore hardly possible to link resistin to the cardiodepressant effect exerted by human adipocytes described in this study. Another adipokine with a potential role in cardiovascular pathobiology is apelin. Apelin has been shown to exert potent positive inotropic effect on normal and failing myocardium. 25, 26 Furthermore, apelin has cardioprotective effects against ischemia and reperfusion injury in rats. 27 Several others adipokines have been identified, but whether these modulate cardiac function is not clear so far. In this context, we have previously shown that human adipocytes exert a highly effective impact by directly and acutely depressing cardiomyocyte contractility in vitro, 11 recently identifying one of these cardiodepressant factors as FABP4. 28 In subsequent studies, we plan to examine if the effects on contraction of isolated hearts are initiated through the action of FABP4 or whether other adipocyte-derived factors are involved. Growing evidence supports a role for epicardial fat tissue in the pathogenesis of coronary atherosclerosis and myocardial dysfunction. 29 Epicardial fat tissue is a visceral fat depot located around the heart, in close contact with the adventitia of the coronary arteries and the underlying myocardium. Similar to visceral adipose tissue, epicardial fat is a source of several inflammatory mediators, including TNF-a, IL-6, IL-1b, 30, 31 as well as adipokines with antiinflammatory properties, such as adiponectin and adrenomedullin. [31] [32] [33] Interestingly, patients with coronary artery disease have higher epicardial fat tissue levels of proinflammatory adipocytokines but lower levels of adiponectin. 31 Therefore, an imbalance between pro-and anti-inflammatory mediators in epicardial adipose tissue may contribute to obesity-related atherosclerosis and cardiac dysfunction. Considering the key role of systemic and local inflammation in epicardial fat tissue in the pathogenesis of obesity-related cardiovascular complications, and that several proinflammatory cytokines may contribute to cardiac dysfunction in severe inflammatory process, 34 we tested whether inflammatory cytokines are responsible for the adipocytesinduced cardiodepressant effect. Human adipocytes release the proinflammatory cytokines TNF-a, IL-6 and IL-1b in low concentrations in our in vitro system; they had, however, in these concentrations no effect on heart contractility or CF. This study with isolated hearts reinforces the physiological relevance of adipocyte factors in the pathogenesis of obesityrelated cardiac dysfunction. Obesity has been associated with heart failure, which is characterized by both a systolic and diastolic dysfunction. Wong et al. 3 showed that reduced left ventricular systolic and diastolic function is common in Role of adipose tissue in cardiac dysfunction C Look et al obese subjects without other comorbidities such as coronary artery disease, diabetes mellitus or systemic hypertension. Furthermore, echocardiographic measurements of myocardial tissue velocity and strain index decrease with increasing degrees of body weight, suggesting early myocardial depression even in overweight subjects. 3 In this study, we observed a significant depressive effect on both CR and RR that correspond with the cardiac functional changes observed in obese subjects. Interestingly, we observed a cardiodepressant effect with the AM obtained from both lean and overweight women. Although the degree of cardiodepressant activity varies between the different preparations, we did not observe a correlation with body mass index. However, we have to consider the limitations of this study. We observed that human adipocytes release cardiodepressant factors in vitro. How to translate this finding to in vivo situation remains to be elucidated in future studies. It is possible that the fat distribution, for example, an increased epicardial fat tissue, determines whether these adipocyte factors contribute to cardiac dysfunction in vivo. Another possibility is that changes on adipose tissue in vivo such as increased inflammatory cells infiltration in adipose tissue as observed in obesity have the key role whether adipocytes secrete these factors or not. For this issue, further studies are necessary.
It is well established that arachidonic acid metabolites have an important role in the regulation of coronary circulation. The vascular endothelium is a main site for arachidonic acid metabolization, releasing vasocontracting and/or vasorelaxing substances. 35 It has been previously shown that the vasoconstrictor effect of arachidonic acid is COX dependent. 14 This endothelium-derived vasoconstriction affects the local microcirculation with a consequent ischemia and heart dysfunction. In this study, we could exclude that the cardiodepressant effect is a result of an endothelial COX-dependent contraction of the coronary vessels, because inhibition of COX had no effect on cardiodepression induced by adipocyte factors.
In conclusion, the results of our data indicate that human subcutaneous adipocytes secrete factors with a strong acute depressant effect on cardiac force generation and coronary flow due to contraction of the coronary vessels. These findings suggest a direct involvement of adipose tissue in the pathogenesis of myocardium dysfunction, thus explaining the strong association between obesity and heart failure.
